BRPI0712629B8 - método para a detecção da apoptose e método para a identificação de uma célula de câncer humano - Google Patents

método para a detecção da apoptose e método para a identificação de uma célula de câncer humano

Info

Publication number
BRPI0712629B8
BRPI0712629B8 BRPI0712629A BRPI0712629A BRPI0712629B8 BR PI0712629 B8 BRPI0712629 B8 BR PI0712629B8 BR PI0712629 A BRPI0712629 A BR PI0712629A BR PI0712629 A BRPI0712629 A BR PI0712629A BR PI0712629 B8 BRPI0712629 B8 BR PI0712629B8
Authority
BR
Brazil
Prior art keywords
apoptosis
cancer cell
identifying
human cancer
detecting apoptosis
Prior art date
Application number
BRPI0712629A
Other languages
English (en)
Inventor
Ashkenazi Avi
D Austin Cary
A Lawrence David
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of BRPI0712629A2 publication Critical patent/BRPI0712629A2/pt
Publication of BRPI0712629B1 publication Critical patent/BRPI0712629B1/pt
Publication of BRPI0712629B8 publication Critical patent/BRPI0712629B8/pt
Publication of BRPI0712629C1 publication Critical patent/BRPI0712629C1/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/686—Anti-idiotype
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Abstract

método para a detecção da apoptose, método para a identificação de uma célula de câncer humano e kit para observar a apoptose. a invenção fornece materiais e métodos para observação de fragmentos de proteínas produzidos durante a apoptose a fim de observar esse processo em células de mamíferos. exemplos de realizações da presnete invenção podem ser utilizados, por exemplo, para observar apoptose a fim de examinar a sensibilidade de uma célula de câncer de mamífero a agentes indutores da apoptose.
BRPI0712629A 2006-06-20 2007-06-20 método para a detecção da apoptose e método para a identificação de uma célula de câncer humano BRPI0712629C1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81495506P 2006-06-20 2006-06-20
US60/814,955 2006-06-20
PCT/US2007/014382 WO2007149486A2 (en) 2006-06-20 2007-06-20 Methods and materials for observing apoptosis by detecting fragments of clathrin-pathway components

Publications (4)

Publication Number Publication Date
BRPI0712629A2 BRPI0712629A2 (pt) 2012-10-23
BRPI0712629B1 BRPI0712629B1 (pt) 2018-07-17
BRPI0712629B8 true BRPI0712629B8 (pt) 2018-09-25
BRPI0712629C1 BRPI0712629C1 (pt) 2021-07-27

Family

ID=38834096

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0712629A BRPI0712629C1 (pt) 2006-06-20 2007-06-20 método para a detecção da apoptose e método para a identificação de uma célula de câncer humano

Country Status (14)

Country Link
US (1) US8198033B2 (pt)
EP (1) EP2044434B1 (pt)
JP (1) JP5222845B2 (pt)
KR (1) KR101433971B1 (pt)
CN (1) CN101535805B (pt)
AU (1) AU2007261405B2 (pt)
BR (1) BRPI0712629C1 (pt)
CA (1) CA2655460C (pt)
IL (1) IL195973A (pt)
MX (1) MX2008016170A (pt)
NZ (1) NZ574009A (pt)
RU (1) RU2450273C2 (pt)
WO (1) WO2007149486A2 (pt)
ZA (1) ZA200900043B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5133842B2 (ja) * 2008-10-14 2013-01-30 国立大学法人 千葉大学 癌が疑われる患者または癌患者由来の組織の癌部と非癌部との判別方法およびそれに用いる判別試薬
RU2508542C1 (ru) * 2012-07-16 2014-02-27 Полина Михайловна Шварцбурд Экспресс-способ определения риска злокачественности клеток
WO2015138638A1 (en) 2014-03-11 2015-09-17 Theraly Pharmaceuticals, Inc. Long acting trail receptor agonists for treatment of autoimmune diseases
WO2017106627A1 (en) 2015-12-17 2017-06-22 The Johns Hopkins University Ameliorating systemic sclerosis with death receptor agonists
WO2017177148A1 (en) 2016-04-07 2017-10-12 The Johns Hopkins University Compositions and methods for treating pancreatitis and pain with death receptor agonists
GB201615842D0 (en) 2016-09-16 2016-11-02 Ucl Business Plc Cell death biomarker

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935801A (en) * 1996-03-29 1999-08-10 Dana-Farber Cancer Institute Monoclonal antibody that detects apoptotic antigen
CA2324995A1 (en) * 1998-04-17 1999-10-28 University Of Vermont And State Agricultural College Methods and products related to metabolic interactions in disease
WO2000017648A1 (en) * 1998-09-24 2000-03-30 Promega Corporation Apoptosis marker antibodies and methods of use
WO2002052032A1 (fr) * 2000-12-22 2002-07-04 Chugai Seiyaku Kabushiki Kaisha Procede servant a mesurer la mort cellulaire de cellules ciblees
US6797677B2 (en) 2002-05-30 2004-09-28 Afton Chemical Corporation Antioxidant combination for oxidation and deposit control in lubricants containing molybdenum and alkylated phenothiazine
JP2007516693A (ja) * 2003-06-09 2007-06-28 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・ミシガン 癌の治療および診断のための組成物および方法

Also Published As

Publication number Publication date
KR101433971B1 (ko) 2014-08-25
RU2450273C2 (ru) 2012-05-10
EP2044434A2 (en) 2009-04-08
IL195973A (en) 2011-05-31
NZ574009A (en) 2012-01-12
JP5222845B2 (ja) 2013-06-26
MX2008016170A (es) 2009-02-03
BRPI0712629A2 (pt) 2012-10-23
CN101535805B (zh) 2014-02-12
CN101535805A (zh) 2009-09-16
CA2655460C (en) 2014-05-20
WO2007149486A3 (en) 2008-03-20
EP2044434B1 (en) 2015-11-18
WO2007149486A2 (en) 2007-12-27
AU2007261405B2 (en) 2013-02-14
KR20090024795A (ko) 2009-03-09
RU2009101512A (ru) 2010-07-27
US20110244473A1 (en) 2011-10-06
AU2007261405A1 (en) 2007-12-27
IL195973A0 (en) 2009-09-01
JP2009541741A (ja) 2009-11-26
CA2655460A1 (en) 2007-12-27
BRPI0712629B1 (pt) 2018-07-17
ZA200900043B (en) 2010-03-31
US8198033B2 (en) 2012-06-12
BRPI0712629C1 (pt) 2021-07-27

Similar Documents

Publication Publication Date Title
Geijer et al. Elongation factor ELOF1 drives transcription-coupled repair and prevents genome instability
BRPI0712629B8 (pt) método para a detecção da apoptose e método para a identificação de uma célula de câncer humano
Mittasch et al. Regulated changes in material properties underlie centrosome disassembly during mitotic exit
BR112014015152A2 (pt) métodos e materiais para a avaliação da perda de heterozigosidade
CL2008002917A1 (es) Anticuerpos especificos para 5-ennolpiruvilshikimato-3-fosfato sintetasa (epsps) doble mutante; hibridoma productor; método para generar dichos anticuerpos; eodo de detección de dicha enzima epsps doble mutante en una composición; kit para detectar la presencia de dicha epsps doble mutante en la composición.
BRPI1013688A8 (pt) Proteínas de ligação de il-17.
CL2007003649A1 (es) Un conjugado de molecula asociado a anticuerpo monoclonal humano anti-cd70; composicion que comprende al conjugado de molecula asociado a anticuerpo; metodo de inhibicion del crecimiento de celulas tumorales que expresan cd70.
ATE450547T1 (de) Eml4-alk-fusionsgen
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
BR112012031071A2 (pt) 8-proteínas de ligação à il-1
TW200626899A (en) Frizzled proteins and detection and treatment of cancer
EA200801942A1 (ru) Способ предотвращения или уменьшения риска возникновения рака с использованием пептидов на основе белков нервных волокон
NZ578283A (en) Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring
BRPI0912927A2 (pt) "método de detectar um tumor independente de vegf em um indivíduo e método de tratar um tumor independente de vegf em um indivíduo"
HU230068B1 (hu) Nemhagyományos transzmisszibilis ágens biológiai mintabeli jelenlétének kimutatásán alapuló eljárás szubakut transzmisszibilis spongiform encephalopathia diagnózisára
MX2009002787A (es) Composiciones y métodos para prevenir el cáncer con cupredoxinas.
WO2009075797A3 (en) Biomarkers for predicting the sensitivity of cells to immunomodulatory compounds during treatment of non-hodgkin's lymphoma
ATE414277T1 (de) Verfahren zur verhinderung der zeitabhängigen rna-expression in biologischen zellen
FR2900936B1 (fr) Procede et methodes de detection de la maladie d'alzheimer
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen
MX2009001070A (es) Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma.
Rocco et al. Genomic damage in human sperm cells exposed in vitro to environmental pollutants
BR112014015424A2 (pt) detecção de células derivadas de tecido do cordão umbilical humano
AR058510A1 (es) Procedimiento de diagnostico de enfermedades hepaticas y de muestreo de moleculas para el tratamiento de estas enfermedades
Pickering et al. In vitro FANCD2 monoubiquitination by HHR6 and hRad18

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/07/2018, OBSERVADAS AS CONDICOES LEGAIS. (CO) REFERENTE A RPI 2480 DE 17/07/2018, QUANTO AO ENDERECO DA DEPOSITANTE, REGULARIZACAO DO QUADRO DE INVENTORES.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/06/2007, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO